Pretraga
Rezultati
Lower than standard doses of irinotecan (cpt-11) in the treatment of metastatic colorectal carcinoma (MCC) [2005]
Nikolić-Tomašević, ZoricaWhat patients want to know about disease and treatment [2004]
Nikolić-Tomašević, ZoricaFamily and personal cancer history in young patients with pregnancy associated breast cancer
[2016]
Tomašević, Zorica Risk for HER2 3+ breast cancer brain metastases significantly diminished five years after diagnosis [2011]
Tomašević, ZoricaHyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: A prospective randomized trial [2000]
Jeremic, B.; Shibamoto, Y.; Milicic, B.; Nikolic, N.; Dagovic, A.Randomized phase III study (SPEAR) of picoplatin plus best supportive care (BSC) or BSC alone in patients (pts) with SCLC refractory or progressive within 6 months after first-line platinum-based chemotherapy. [2010]
Ciuleanu, Tudor E; Samarzjia, M; Demidchik, Y; Beliakouski, V; Rancic, M; Bentsion, DL; Orlov, SV; Schaeffier, BA; De, Jager RL; Breitz, HBBevacizumab biosimilar (MB02) and reference bevacizumab in patients with stage IIIB/IV non-squamous non-small cell lung cancer (NSCLC) (STELLA study): Multiple Imputation analysis.
[2021]
Trukhin, Dmytro; Poddubskaya, Elena; Andric, Zoran G
Garcia, Fernanda;
Myelopreservation and reduced use of supportive care with trilaciclib in patients with small cell lung cancer. [2020]
Jared, Weiss; Jerome, Goldschmidt; Andric, Zoran GRelation of methylenetetrahydrofolate reductase C677T polymorphism to chronic myeloid leukemia in Serbia.
[2011]
Janković, Radmila Length of treatment after partial or complete remission in immunotherapy for metastatic melanoma: An EUMelaReg real world study [2024]
Asher, Nethanel; Mohr, Peter; Ellebaek, Eva; Bender, Marc; Mangana, Joanna; Kandolf, Lidija O; Gavrilova, Iva; Ascierto, Paolo Antonio; Gogas, Helen; Rutkowski, Piotr;
Schadendorf, Dirk; Bastholt, Lars; Weichenthal, Michael;
Filters
By type
- 156